Successful treatment of pseudomyxoma peritonei of ovarian origin with cis-platinum, doxorubicin, and cyclophosphamide.

Abstract

Pseudomyxoma peritonei is a rare disease characteristically secondary to mucin-producing adenocarcinomas of the ovary and appendix. Though, as a rule, not invasive or metastatic, death occurs secondary to gastrointestinal dysfunction. This is the first case of pseudomyxoma peritonei secondary to an ovarian primary possibly cured by systemic cis-platinum, doxorubicin, and cyclophosphamide.

• Authors: C M Jones 3rd, H D Homesley
• Journal: Gynecologic oncology (Gynecol Oncol) Vol. 22 Issue 2 Pg. 257-9 (Oct 1985) ISSN: 0090-8258 [Print] United States
• PMID: 4054721 (Publication Type: Case Reports, Journal Article)

Chemical References

• Doxorubicin
• Cyclophosphamide
• Cisplatin

Topics

• Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
• Cisplatin (administration & dosage)
• Cyclophosphamide (administration & dosage)
• Cystadenocarcinoma (drug therapy, pathology)
• Doxorubicin (administration & dosage)
• Female
• Humans
• Middle Aged
• Ovarian Neoplasms (drug therapy, pathology)
• Peritoneal Neoplasms (drug therapy, pathology)